---
input_text: 'The range of haploidentical transplant protocols in sickle cell disease:
  all haplos are not created equally.The ideal curative therapy for sickle cell disease
  (SCD) must be applicable across all ages and include individuals with strokes and
  preexisting heart, lung, and kidney disease. Myeloablative, matched sibling donor
  hematopoietic stem cell transplant (HCT) for children with SCD has shown excellent
  outcomes over the past 3 decades but has been restricted due to the limited availability
  of a human leukocyte antigen-matched sibling donor (10%-15%) and increased treatment-related
  death in adults with myeloablative conditioning. To overcome these 2 significant
  barriers to curative therapy in SCD, related haploidentical HCT has become an active
  area of research. The use of related haploidentical donors (first- and second-degree
  relatives) increases the donor pool to at least 90% of those eligible across the
  life span. Importantly, most adults, even with strokes or significant comorbidities,
  can tolerate the nonmyeloablative conditioning regimen without treatment-related
  death. Since 2013, at least 3 related haploidentical HCT strategies have emerged
  as potential curative therapies for SCD: (1) a nonmyeloablative, T-cell replete,
  bone marrow transplant with thiotepa and posttransplant cyclophosphamide with a
  goal of complete donor chimerism; (2) a nonmyeloablative, in vivo T-cell depletion,
  using peripheral blood stem cells (PBSCs) with a goal of stable mixed donor-recipient
  chimerism; and (3) a myeloablative, ex vivo T-cell depletion using PBSCs and advanced-technology
  graft manipulation, with a goal of complete donor chimerism. We review the similarities,
  differences, outcomes, and gaps in knowledge with these 3 haploidentical HCT approaches
  for SCD.'
raw_completion_output: |-
  action: <haploidentical transplant protocols; myeloablative, matched sibling donor hematopoietic stem cell transplant (HCT); related haploidentical HCT; nonmyeloablative conditioning regimen; bone marrow transplant with thiotepa and posttransplant cyclophosphamide; in vivo T-cell depletion, using peripheral blood stem cells (PBSCs); ex vivo T-cell depletion using PBSCs and advanced-technology graft manipulation>
  disease: <sickle cell disease (SCD)>
  symptom: <strokes; significant comorbidities>
  action_to_disease: <haploidentical transplant protocols TREATS sickle cell disease (SCD); myeloablative, matched sibling donor hematopoietic stem cell transplant (HCT) TREATS sickle cell disease (SCD); related haploidentical HCT TREATS sickle cell disease (SCD); bone marrow transplant with thiotepa and posttransplant cyclophosphamide TREATS sickle cell disease (SCD); in vivo T-cell depletion, using peripheral blood stem cells (PBSCs) TREATS sickle cell disease (SCD); ex vivo T-cell depletion using PBSCs and advanced-technology graft manipulation TREATS sickle cell disease (SCD)>
  action_to_symptom: <nonmyeloablative conditioning regimen IS USED TO TREAT significant comorbidities>
  triples: <haploidentical transplant protocols TREATS sickle cell disease (SCD); myeloablative, matched sibling donor hematopoietic stem cell transplant (HCT) TREATS sickle cell disease (SCD); related haploidentical HCT TREATS sickle cell disease (SCD); bone marrow transplant with thiotepa and posttransplant cyclophosphamide TREATS sickle cell disease (SCD); in vivo T-cell depletion, using peripheral blood stem cells (PBSCs) TREATS sickle cell disease (SCD); ex vivo T-cell depletion using PBSCs and advanced-technology graft manipulation TREATS sickle cell disease (SCD); nonmyeloablative conditioning regimen IS USED TO TREAT significant comorbidities>
prompt: |+
  From the text below, extract the following entities in the following format:

  subject: <the value for subject>
  predicate: <the value for predicate>
  object: <the value for object>
  qualifier: <A qualifier for the statements, e.g. "NOT" for negation>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  nonmyeloablative conditioning regimen IS USED TO TREAT significant comorbidities>

  ===

extracted_object:
  triples:
    - subject: haploidentical transplant protocols
      predicate: TREATS
      object: sickle cell disease (SCD)
    - subject: myeloablative, matched sibling donor hematopoietic stem cell transplant
        (HCT)
      predicate: TREATS
      object: sickle cell disease (SCD)
    - subject: haploidentical HCT
      predicate: TREATS
      object: sickle cell disease
      subject_qualifier: related
      object_qualifier: (SCD)
    - subject: bone marrow transplant with thiotepa and posttransplant cyclophosphamide
      predicate: TREATS
      object: sickle cell disease (SCD)
    - subject: in vivo T-cell depletion, using peripheral blood stem cells (PBSCs)
      predicate: TREATS
      object: sickle cell disease (SCD)
    - subject: ex vivo T-cell depletion using PBSCs and advanced-technology graft
        manipulation
      predicate: TREATS
      object: sickle cell disease (SCD)
    - subject: nonmyeloablative conditioning regimen
      predicate: IS USED TO TREAT
      object: significant comorbidities
  action:
    - <haploidentical transplant protocols
    - MAXO:0000149
    - related haploidentical HCT
    - nonmyeloablative conditioning regimen
    - bone marrow transplant with thiotepa and posttransplant cyclophosphamide
    - in vivo T-cell depletion, using peripheral blood stem cells (PBSCs)
    - ex vivo T-cell depletion using PBSCs and advanced-technology graft manipulation>
  disease:
    - MONDO:0007374
  symptom:
    - <strokes
    - significant comorbidities>
  action_to_disease:
    - subject: haploidentical transplant protocols
      predicate: TREATS
      object:
        - MONDO:0007374
    - subject: MAXO:0000149
      predicate: TREATS
      object:
        - MONDO:0007374
    - subject: related haploidentical HCT
      predicate: TREATS
      object:
        - MONDO:0007374
    - subject: bone marrow transplant with thiotepa and posttransplant cyclophosphamide
      predicate: TREATS
      object:
        - MONDO:0007374
    - subject: in vivo T-cell depletion, using peripheral blood stem cells (PBSCs)
      predicate: TREATS
      object:
        - MONDO:0007374
    - subject: ex vivo T-cell depletion using PBSCs and advanced-technology graft
        manipulation
      predicate: TREATS
      object:
        - MONDO:0007374
  action_to_symptom:
    - subject: nonmyeloablative conditioning regimen
      predicate: IS USED TO TREAT
      object:
        - significant comorbidities
named_entities:
  - id: MAXO:0001001
    label: genetic therapies
  - id: MONDO:0011382
    label: sickle cell disease
  - id: MONDO:0100096
    label: COVID-19
  - id: MONDO:0005087
    label: Respiratory disease
  - id: MONDO:0007374
    label: <Sickle cell disease (SCD)
  - id: MONDO:0005632
    label: acute chest syndrome
  - id: MONDO:0005550
    label: infections
  - id: MONDO:0005081
    label: preeclampsia
  - id: MONDO:0005030
    label: intrauterine growth restriction
  - id: MONDO:0000831
    label: Thrombosis
  - id: MONDO:0005080
    label: Portal hypertension
  - id: MONDO:0005149
    label: Pulmonary Hypertension
  - id: MAXO:0000756
    label: transfusion
  - id: MAXO:0000747
    label: hematopoietic stem cell transplantation
  - id: MONDO:0005279
    label: Pulmonary embolism
  - id: HP:0025179
    label: Ground glass opacities
  - id: MAXO:0000118
    label: immunizations
  - id: HP:0001297
    label: stroke
  - id: MONDO:0002280
    label: anemia
  - id: HP:0001511
    label: intrauterine growth retardation
  - id: HP:0001518
    label: low birth weight
  - id: MAXO:0001006
    label: full blood count
  - id: MAXO:0000825
    label: reticulocyte count
  - id: MAXO:0000427
    label: brain MRI
  - id: HP:0012532
    label: chronic pain
  - id: MONDO:0005098
    label: stroke
  - id: MONDO:0005192
    label: Pancreatic cancer
  - id: MONDO:0018874
    label: Acute myeloid leukemia
  - id: MONDO:0009693
    label: Multiple myeloma
  - id: MONDO:0800385
    label: iron overload
  - id: MONDO:0005300
    label: Chronic Kidney Disease (CKD)
  - id: MONDO:0003139
    label: Mesangioproliferative Glomerulonephritis
  - id: MONDO:0006835
    label: Minimal Change Disease
  - id: MONDO:0100313
    label: Focal Segmental Glomerulosclerosis
  - id: MONDO:0001085
    label: Interstitial Nephritis
  - id: HP:0000093
    label: Proteinuria
  - id: MAXO:0000969
    label: optical coherence tomography (OCT)
  - id: HP:0000505
    label: visual impairment
  - id: MONDO:0013730
    label: acute graft-versus-host disease (GVHD)
  - id: MONDO:0100467
    label: hypertensive disorder of pregnancy
  - id: HP:0000822
    label: high blood pressure
  - id: MONDO:0005170
    label: Myeloid malignancies
  - id: MONDO:0004745
    label: priapism
  - id: HP:0012213
    label: Decreased GFR
  - id: MONDO:0005570
    label: hematologic diseases
  - id: MAXO:0010203
    label: echocardiography
  - id: HP:0012531
    label: Pain
  - id: MAXO:0000536
    label: <Chorionic villus sampling (CVS)
  - id: MONDO:0011399
    label: Alpha thalassemia
  - id: MONDO:0019402
    label: Beta thalassemia
  - id: MONDO:0000984
    label: Thalassemia
  - id: MONDO:0043544
    label: Nosocomial infections
  - id: MAXO:0001479
    label: allogeneic hematopoietic stem cell transplantation
  - id: MAXO:0000571
    label: CT
  - id: MONDO:0007145
    label: Aplasia cutis congenita
  - id: MONDO:0005246
    label: Osteomyelitis
  - id: MONDO:0020517
    label: Eosinophilic granuloma
  - id: MAXO:0000447
    label: Surgical removal
  - id: HP:0000989
    label: Pruritus
  - id: MAXO:0000149
    label: myeloablative, matched sibling donor hematopoietic stem cell transplant
      (HCT)
